Glenn Geidel
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Beyond the First Graft: Skin Cancer Risk and Risk Stratification in Retransplanted Solid Organ Recipients.
Journal: The British journal of dermatology
Published: May 05, 2026
Topology and Quality of Life of Cutaneous T-Cell-Lymphomas: A Cross-sectional Study of 153 Patients.
Topology and Quality of Life of Cutaneous T-Cell-Lymphomas: A Cross-sectional Study of 153 Patients.
Journal: Clinical and experimental dermatology
Published: April 08, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.
Journal: Journal for immunotherapy of cancer
Published: February 23, 2026
Real-world treatment patterns in stage III and IV melanoma patients: insights from a global multi-center chart review study.
Journal: Frontiers in immunology
Published: February 18, 2026
Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma.
Journal: International journal of cancer
Published: February 18, 2026
Translating ctDNA into cutaneous melanoma care: An international expert survey.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 13, 2026
Detection and prognostic role of circulating cancer-associated fibroblasts in the blood of melanoma patients.
Journal: Frontiers in cell and developmental biology
Published: December 23, 2025
Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany.
Journal: International journal of cancer
Published: December 18, 2025
Enhanced overall and progression-free survival in advanced melanoma patients undergoing targeted therapy alongside antithrombotic treatment - Insights from a multicenter study involving 1296 patients from the prospective skin cancer registry ADOReg.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 12, 2025
The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint Inhibition.
Journal: International journal of cancer
Published: September 09, 2025
Circulating cellular communication network factor 1 (CCN1) as a liquid biopsy marker indicating progression in advanced melanoma.
Journal: Journal of translational medicine
Published: September 05, 2025
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 31, 2025
Last Updated: 09/26/2026